A. M. Pappas & Associates is an employee-owned, international life science venture development company known for its innovative business model that combines specialized transactional advisory services with investment management.

The company's Fund Management group has approximately $150 million under management and is currently deploying its most recent venture capital fund. AMP&A's Transaction Advisory group provides a broad range of licensing, M&A, technology assessment, and other advisory services to the life science industry, having represented more than 100 different companies in the U.S. and Europe over the past five years.